Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study
- PMID: 32738879
- PMCID: PMC7395419
- DOI: 10.1186/s12905-020-01033-2
Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study
Abstract
Background: Gender wise differences exist in anti-hypertensive treatment outcomes, yet still un-explored in Pakistan. Thus, we aimed to estimate the clinical efficacy of four different anti-hypertensive regimens in hypertensive women of Punjab, Pakistan.
Methods: A longitudinal cohort study of 12 months duration was conducted by enrolling 300 hypertensive women on four anti-hypertensive regimens. Chi-square for significance, logistic regression for association and multilevel regression for changes in outcomes were used.
Results: Majority of subjects were < 60 years of age, weighing > 65 Kg, having family history, married and hailing from urban areas, with diabetes as the most common comorbidity. Hypertension, adjusted for covariates, was significantly associated with salt intake (OR:2.27, p < 0.01) and physical activity (OR;2.16, p < 0.01). High-risk subjects, compared to low-risk, were consuming more fat (OR;1.54), meat (OR; 2), salt (OR; 2.48) and even vegetables/fruits (OR;3.43). Compared to baseline, the maximum reduction in BP was observed with combination therapy, N-GITS+LTN + HCT (SBP; - 50.17, p < 0.01, DBP; - 16.55, p < 0.01), followed by N-GITS alone (SBP; - 28.89, p < 0.01, DBP; - 12.21, p < 0.01). Compared to baseline, adjusted for treatment effects, significant reductions in SBP (low-risk; - 17.92, p < 0.01 high-risk; - 19.48, p < 0.01) and DBP (low-risk; - 17.92, p < 0.01, high-risk; - 19.48, p < 0.01) were observed in low and high risk patients. Among all four cohorts, orthostatic hypotension and edema were common in N-GITS+LTN + HCT only, but variable effects were observed on biochemical values; urea, BSR and creatinine.
Conclusion: In conclusion, compared to a single agent, combination therapy conferred improved BP controls followed by N-GITS alone in low and high risk women with manageable side effects.
Keywords: Combination therapy; Hypertension; Losartan; Nifedipine-GITS; Pakistan; Punjab; Women.
Conflict of interest statement
Authors declared that they have no conflicts of interest.
Figures
Similar articles
-
A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.J Hum Hypertens. 1998 Oct;12(10):693-9. doi: 10.1038/sj.jhh.1000687. J Hum Hypertens. 1998. PMID: 9819017 Clinical Trial.
-
Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.Clin Ther. 1996 May-Jun;18(3):411-28. doi: 10.1016/s0149-2918(96)80022-1. Clin Ther. 1996. PMID: 8829017 Clinical Trial.
-
Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.Clin Drug Investig. 2011;31(9):631-42. doi: 10.2165/11588970-000000000-00000. Clin Drug Investig. 2011. PMID: 21591818
-
Current treatment of patients with hypertension: therapeutic implications of INSIGHT.Drugs. 2003;63(14):1435-44. doi: 10.2165/00003495-200363140-00001. Drugs. 2003. PMID: 12834362 Review.
-
Long-term protection in at-risk hypertensive patients--a role for nifedipine GITS?Blood Press. 2002;11(2):106-9. doi: 10.1080/08037050211264. Blood Press. 2002. PMID: 12035870 Review.
References
-
- Organization WH Global Health Observatory (GHO) data 2015. Retrieved. 2015;3:23.
-
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2224–2260. doi: 10.1016/S0140-6736(12)61766-8. - DOI - PMC - PubMed
-
- Ljungman C, Kahan T, Schioler L, Hjerpe P, Hasselstrom J, Wettermark B, Bostrom KB, Manhem K. Gender differences in antihypertensive drug treatment: results from the Swedish primary care cardiovascular database (SPCCD) J Am Soc Hypertens. 2014;8(12):882–890. doi: 10.1016/j.jash.2014.08.015. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical